Bermuda Tech Week 2019 to Celebrate Innovation and Explore Opportunities for Growth
20.8.2019 17:27:00 EEST | Business Wire | Press release
Registration is under way and filling fast for Bermuda Tech Week 2019 which will take place at the Hamilton Princess & Beach Club from October 14-18, 2019.
The programme of insightful and engaging events will explore future opportunities and challenges presented by emerging technologies such as artificial intelligence, blockchain, digital assets, insurtech and virtual reality. It will showcase Bermuda’s ongoing success in creating a welcoming, stable and well-regulated environment where technology and start-up companies can thrive.
“Bermuda has a long history of innovation so we understand and recognise the power of technology to positively impact both the economy and society,” said Bermuda Premier David Burt. “Over the past two years, we have built on our strength as a global leader in regulating the risks associated with the global insurance industry to develop a clear regulatory framework around managing the risks associated with Fintech. Our progressive approach has drawn accolades in U.S. Senate hearings and from an SEC commissioner in providing the kind of guidance, oversight and clarity needed for the industry to deliver on its mission to make financial services more accessible to people around the globe. Being at the forefront of innovation will help drive economic growth and job creation so we remain committed to being at the forefront of emerging trends, which is why we look forward to hosting Bermuda Tech Week 2019 in October.”
Andy Burrows, CEO of the Bermuda Business Development Agency (BDA), said: “Bermuda Tech Week 2019 comes at an ideal time and builds on the momentum we have seen in the market, driven by new and innovative legislation. Industry, government and regulatory authorities here in Bermuda work closely together to deliver an environment that facilitates progress. This is reflected in the programme of events that our team has put together. Our aim is for all attendees to come away with a better knowledge of how new technologies can be deployed to drive efficiencies in business and, importantly, what Bermuda has to offer the global market as a domicile of choice for tech companies and start-ups.”
At the heart of Bermuda Tech Week 2019 is the Bermuda Tech Summit which will take place on Wednesday, October 16 under the theme ‘Focused on the Future’. Bermuda’s Premier, David Burt, is set to deliver an opening address. Hosted by the BDA, in partnership with FinTech Bermuda, the all-day summit is free to attend and will explore the transformational impact of technology on investment and business models in a wide range of industry sectors relevant to Bermuda, from hospitality and financial services to telecommunications and insurance. Attendees will gain an in-depth understanding of how Bermuda’s business environment is facilitating innovation.
Events throughout the week will feature an array of speakers and attendees from across Bermuda’s government, industry and regulatory authorities along with some of the world’s most dynamic technology companies, including BitMEX, Blade, ChainThat, Circle, Data Innovation Labs, Flyt, Muckr.ai, SeaHeal, The Giving Block, Uulala, X and XBTO. Leading hotel brands AccorHotels (Fairmont), Hilton, Marriott International and Wyndham Hotel Group will also participate.
The schedule for Bermuda Tech Week 2019 includes:
- Liquidity Summit – a fintech event focused on leading and emerging trends across the world of finance. Presented by Hub Culture and the Ven digital currency, this event will take place on Monday, October 14 and Tuesday, October 15
- Defend and Detect – a technology and technique event hosted by KPMG Bermuda showcasing how technology and business ideas can come together to solve complex challenges in managing regulatory risk and compliance. This event is invitation-only and will take place on Tuesday, October 15
- Hello World – the world’s first AI to AI event hosted by Zeke.ai, Hub Culture’s emergent intelligent machine. This event will take place on Thursday, October 17
- Tech Beach ‘FinTech Innovation Island’ – coming to Bermuda for the first time, this will be an innovative space to explore opportunities for collaboration. Presented by Tech Beach, in partnership with the BDA and the Bermuda Tourism Authority (BTA), this event will be held on Thursday, October 17 and Friday, October 18
To register for events, visit www.bermudatechweek.bm, or if your company is interested in sponsoring or hosting additional events throughout the week, contact bermudatechweek@bda.bm. For a limited period only, take advantage of the $250/night preferred room rate at the Hamilton Princess & Beach Club by clicking here.
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190820005544/en/
Contact information
Nicola Stevens
nstevens@bda.bm
+1 441 292 7774
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
